Viewing Study NCT01924260


Ignite Creation Date: 2025-12-25 @ 2:06 AM
Ignite Modification Date: 2025-12-26 @ 3:46 AM
Study NCT ID: NCT01924260
Status: COMPLETED
Last Update Posted: 2022-08-02
First Post: 2013-08-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Alisertib and Gemcitabine Hydrochloride in Treating Patients With Solid Tumors or Pancreatic Cancer
Sponsor: Edward Kim
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module